These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16482464)

  • 1. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
    Küfer R; Hautmann R
    Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene expression profiling of renal cell carcinoma and clinical implications.
    Rogers CG; Tan MH; Teh BT
    Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular profiling of renal cancer: the journey to clinical application.
    Ribal MJ
    Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
    Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
    Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microarrays for the identification of molecular markers in the diagnosis and therapy of renal cell carcinomas].
    Sültmann H; Poustka A
    Urologe A; 2006 Mar; 45(3):297-8, 300-4. PubMed ID: 16465525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers for predicting prognosis of renal cell carcinoma.
    Nogueira M; Kim HL
    Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of molecular markers in the staging of renal cell carcinoma.
    Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 May; 99(5 Pt B):1208-11. PubMed ID: 17441912
    [No Abstract]   [Full Text] [Related]  

  • 10. [The molecular pathogenesis and prognosis of renal cell carcinoma].
    Serth J
    Urologe A; 2007 Sep; 46(9):1168-9. PubMed ID: 17668170
    [No Abstract]   [Full Text] [Related]  

  • 11. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
    Slabý O; Svoboda M; Michálek J; Vyzula R
    Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.
    Cheng L; Williamson SR; Zhang S; Maclennan GT; Montironi R; Lopez-Beltran A
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):843-64. PubMed ID: 20553210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate molecular classification of kidney cancer subtypes using microRNA signature.
    Youssef YM; White NM; Grigull J; Krizova A; Samy C; Mejia-Guerrero S; Evans A; Yousef GM
    Eur Urol; 2011 May; 59(5):721-30. PubMed ID: 21272993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcriptome expression analyses of pulmonary renal cell carcinoma metastases].
    Wuttig D; Höfling C; Füssel S; Meinhardt M; Herr A; Tennstedt P; Holotiuk O; Baretton G; Meye A; Grimm MO; Rolle A; Wirth MP
    Urologe A; 2007 Sep; 46(9):1291-2. PubMed ID: 17619850
    [No Abstract]   [Full Text] [Related]  

  • 15. Current trends in molecular classification of adult renal tumors.
    Young AN; Dale J; Yin-Goen Q; Harris WB; Petros JA; Datta MW; Wang MD; Marshall FF; Amin MB
    Urology; 2006 May; 67(5):873-80. PubMed ID: 16698345
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel blood biomarkers of human urinary bladder cancer.
    Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does 'granular cell' renal cell carcinoma exist? Molecular and histological reclassification.
    Yang XJ; Takahashi M; Schafernak KT; Tretiakova MS; Sugimura J; Vogelzang NJ; Teh BT
    Histopathology; 2007 Apr; 50(5):678-80. PubMed ID: 17394511
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms.
    Cheng L; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R
    Hum Pathol; 2009 Jan; 40(1):10-29. PubMed ID: 19027455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of genetic markers in the management of kidney cancer.
    Junker K; Ficarra V; Kwon ED; Leibovich BC; Thompson RH; Oosterwijk E
    Eur Urol; 2013 Feb; 63(2):333-40. PubMed ID: 23040205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers in renal cell carcinoma.
    Ljungberg B
    Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.